Likely target: Rs 145
Downward potential: 14%
Firstsource Solutions Ltd has its broken crucial support of Rs 175 with the Relative Strength Index (RSI) making a firm negative crossover. This downward breakdown hints a decline towards Rs 145, which is the next support mark, according to the weekly charts. The immediate resistance comes at Rs 190 levels. CLICK HERE FOR THE CHART
Also Read
Likely target: Rs 2,750 and Rs 2,600
Downward potential: 6% to 10%
The shares of BASF India Ltd have witnessed a consolidation breakdown, as per the weekly chart. This formation represents bearishness, which the stock is currently going through. Subsequently, the breach of the crucial level of Rs 3,200 has further dampened the upside bias. The weak trend suggests that the stock seems to be heading towards Rs 2,750 and Rs 2,600 levels. The Moving Average Convergence Divergence (MACD) has broken the zero line downward indicating a negative outlook for the upcoming sessions. CLICK HERE FOR THE CHART
Strides Pharma Science Ltd (STAR)
Likely target: Rs 470 and Rs 450
Downward potential: 7.50% to 11.50%
The “Lower Low, Lower High” formation has developed a negative sentiment with trend signalling a downward pressure. A broader outlook suggests, that the stock is likely to face resistances on the upside around Rs 530, Rs 575 and Rs 620 and may see a strong sell-off. The breakdown triggers a downside in the direction for Rs 470 and Rs 450 levels, according to the daily chart. The volumes on the negative candles have been strong and seen increased interest of traders. CLICK HERE FOR THE CHART
Tata Communications Ltd (TATACOMM)
Likely target: Rs 1,050
Downward potential: 15%
The shares of Tata Communications Ltd have broken the 200-day moving average (DMA) suggesting weakness in the coming days. Traders and Investors consider stocks as a bullish, when it trades above 200-DMA, any stock falling below is looked as a selling stock. The immediate resistance comes to Rs 1,300 and downside door opens in the direction of Rs 1,050 level, according to the daily chart. . CLICK HERE FOR THE CHART
NATCO Pharma Ltd (NATCOPHARM)
Likely target: Rs 750
Downward potential: 11%
The reversal moves have failed to conquer the significant resistances, which resulted in more selling pressure with downside support remaining weak. The resistance comes at Rs 1,050, Rs 1,000, Rs 935 and now at Rs 890 level. The next nearby support comes at Rs 750 level, according to the daily charts. CLICK HERE FOR THE CHART
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)